Subject: MJNA Financials Posted OCFN News on Lucrative Strategy

SCV Client Spotlight
MJNA Post Q2 Financials: Company earned net income of approximately 1.47 million dollars on gross revenues of 2.40 million dollars
Top PerformerYesterday's Top Performer

Company: Medical Marijuana Inc. (Pink Sheets: MJNA)

End of Day:

Price: 0.0595

Change (%): + 0.0005 (0.85)

Volume: 2,295,660
MJNA Chart

MNJA Posts Financials

Medical Marijuana, Inc. Reports Second Quarter 2012 Revenue and Income Quarter Over Quarter Increase Of Over 1200 Percent From Same Period Last Year

Continue Reading

Hot Stock to WatchHot Stock to Watch

Omega Commercial Finance Corp. (OTCQB: OCFN)

End of Day:

Price: 0.1999

Change (%): + 0 (0.00)

Volume: 7,300
OCFN Chart

Omega Commercial Finance Corporation Implements 1BB Dollar Capital Markets Strategy

MIAMI, FL-(Marketwire - Sep 26, 2012) - Omega Commercial Finance Corporation (OTCQB: OCFN) has authorized the facilitation of a proven capital markets strategy available to public companies that will structure its own internal version of a credit facility. For compliance considerations, limited information can be disclosed however this strategy will be promoted to designated institutional investors and facilitated by licensed financial services firms, yet to be determined. Management's motivation behind this proven capital markets strategy is to generate up to 1-billion dollars in potential lending proceeds for its subsidiary lending companies. This established capital markets strategy in many ways should create an imminent competitive advantage over other small-cap finance companies and private lenders that primarily compete in originating, investing, acquiring, and managing senior-performing commercial real estate mortgage loans, CMBS's, CRE Corporate-debt, and other commercial real estate debt investments in the U.S. and globally.

Continue Reading

Other Small Cap News

Company: OxySure® Systems, Inc. (OTCBB: OXYS)

OxySure (OXYS) and AED Professionals Sign Distribution Agreement

FRISCO, Texas and PALATINE, Ill., Sept. 27, 2012 (GLOBE NEWSWIRE) -- OxySure® Systems, Inc. (OTCBB:OXYS) ("OxySure") and AED Professionals ("AED Professionals") today announced they have signed a distribution agreement for AED Professionals to market and promote OxySure's flagship product, the OxySure Model 615 portable emergency oxygen device, and all related accessories. AED Professionals will offer OxySure as an add-on product to their existing installed base of Automated External Defibrillators (AEDs), and as a companion product for new AED sales. AED Professionals, General Medical Devices, Inc. company is one of the largest distributors of AEDs in the United States.

Continue Reading

Company: Mobivity Holdings Corporation (OTCBB: MFON)

The Carolina Panthers Choose Mobivity as Mobile Marketing Partner With Three-Year Contract

PHOENIX, AZ--(Marketwire - Sep 27, 2012) - Mobivity Holdings Corporation (OTCBB: MFON), an award-winning provider of proprietary mobile marketing technologies and solutions, will be partnering with the Carolina Panthers to allow fans to interact with the organization on the mobile channel by using their mobile marketing platform, as well as in-stadium graphics for live polling and engagement during sporting events.

Continue Reading

Company: Medifocus, Inc. (OTCQX: MDFZF)

Medifocus Inc. Announces S&P Capital IQ Initiates Coverage in Standard & Poor's Factual Stock Reports

COLUMBIA, MD and TORONTO--(Marketwire - Sep 26, 2012) - Medifocus, Inc. (TSX VENTURE: MFS) (OTCQX: MDFZF) announced that S&P Capital IQ has initiated coverage in Standard & Poor's Factual Stock Report.

Medifocus, Inc. develops and commercializes minimally invasive, focused-heat treatment devices and systems. The Company has developed two advanced therapeutic products: Prolieve, for the treatment of BPH (Benign Prostatic Hyperplasia), acquired from Boston Scientific in July 2012, and the APA-1000, microwave technology, for treatment of Breast Cancer. Prolieve is a FDA approved commercial product and is generating revenue.

Continue Reading

Market News

By Morgan Korn: Daily Ticker

Why Men Are Failing in This New Economy

In Hanna Rosin's new book "The End of Men: And the Rise of Women" she argues that women have gained a competitive advantage over men in the workplace.

There are more female employees in 12 of the 15 fastest growing industries and more women are choosing occupations that were previously monopolized by men. Women are even better educated - for every two men who complete their bachelor's degree, there are three female graduates.

In an interview with The Daily Ticker, Rosin says the gender ratio balance has shifted partly because of the 6 million manufacturing jobs lost during the recession - an industry that was heavily employed by men.

Continue Reading

By Ryan Vlastelica:

Wall Street inches up on China, but U.S. data weighs

U.S. stocks rose modestly on Thursday, snapping a five-day losing streak, in the wake of weak data reflecting sluggish economic growth.

The advance came on hopes the Chinese government would take steps to bolster the country's slowing growth, and as U.S. jobless claims fell a lot more than expected in the latest week. Cyclical sectors like energy and financials, which are tied to the pace of growth, rallied.

Jobless claims dropped by 23,000 to 359,000, significantly more than the 4,000 drop that had been expected.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks